Jeff Yass’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-91,405
| Closed | -$35K | – | 11448 |
|
|
2020
Q1 | $35K | Sell |
91,405
-14,356
| -14% | -$5.19K | ﹤0.01% | 9793 |
|
|
2019
Q4 | $43K | Buy |
105,761
+43,869
| +71% | +$72.8K | ﹤0.01% | 9380 |
|
|
2019
Q3 | $124K | Buy |
61,892
+51,562
| +499% | +$104K | ﹤0.01% | 9443 |
|
|
2019
Q2 | $22K | Sell |
10,330
-33,433
| -76% | -$85.4K | ﹤0.01% | 9998 |
|
|
2019
Q1 | $138K | Buy |
+43,763
| New | +$142K | ﹤0.01% | 8107 |
|
|
2018
Q4 | – | Sell |
-145,966
| Closed | -$486K | – | 10441 |
|
|
2018
Q3 | $587K | Buy |
145,966
+129,044
| +763% | +$569K | ﹤0.01% | 6230 |
|
|
2018
Q2 | $64K | Buy |
+16,922
| New | +$44.1K | ﹤0.01% | 9205 |
|
|
2017
Q2 | – | Sell |
-21,379
| Closed | -$77.6K | – | 10143 |
|
|
2017
Q1 | $64K | Sell |
21,379
-16,388
| -43% | -$48.3K | ﹤0.01% | 8537 |
|
|
2016
Q4 | $104K | Sell |
37,767
-1,714
| -4% | -$4.9K | ﹤0.01% | 9069 |
|
|
2016
Q3 | $124K | Buy |
+39,481
| New | +$144K | ﹤0.01% | 7857 |
|
|
2015
Q4 | – | Sell |
-41,420
| Closed | -$345K | – | 10240 |
|
|
2015
Q3 | $350K | Buy |
41,420
+28,368
| +217% | +$261K | ﹤0.01% | 7769 |
|
|
2015
Q2 | $123K | Sell |
13,052
-2,682
| -17% | -$25K | ﹤0.01% | 9588 |
|
|
2015
Q1 | $146K | Sell |
15,734
-34,020
| -68% | -$326K | ﹤0.01% | 8820 |
|
|
2014
Q4 | $460K | Sell |
49,754
-1,541
| -3% | -$13K | ﹤0.01% | 7376 |
|
|
2014
Q3 | $458K | Sell |
51,295
-6,667
| -12% | -$48.5K | ﹤0.01% | 7372 |
|
|
2014
Q2 | $456K | Sell |
57,962
-24,390
| -30% | -$184K | ﹤0.01% | 7657 |
|
|
2014
Q1 | $651K | Sell |
82,352
-39,481
| -32% | -$318K | ﹤0.01% | 6295 |
|
|
2013
Q4 | $759K | Buy |
121,833
+98,861
| +430% | +$518K | ﹤0.01% | 5991 |
|
|
2013
Q3 | $81K | Buy |
+22,972
| New | +$52.3K | ﹤0.01% | 8144 |
|
Jeff Yass's CORV Position: Q2 2020 in Review
Jeff Yass sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 91,405 shares — an estimated $35K sold.
Jeff Yass first reported a position in CORV in Q3 2013 and held it in 19 quarters. The position peaked at $759K in Q4 2013. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.
- Jeff Yass reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
- Jeff Yass sold 91,405 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $35K.
- Jeff Yass first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2013 and held it in 19 quarters.
- Jeff Yass's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $759K in Q4 2013.
- 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.